findmyKOL

Ghulam Saydain, MD

Basic profile

Wayne State University

ORCIDNone on fileNPI
RegionDetroit, MI · MidwestSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ghulam Saydain is a Respiratory physician affiliated with Wayne State University. OpenAlex indexes 61 publications with 879 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
61publications

Distinct works indexed by OpenAlex.

879citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4201 Saint Antoine St
Suite 5v
Detroit, MI 482012153

Telephone

313-745-4525

Registry record last updated 1 Nov 2016.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    75.7%
    beta2-Adrenergic Agonist34.2%
    Albuterol Sulfate Hfa84%Ventolin Hfa16%
    Part D90 patients
    Corticosteroid29.2%
    Trelegy Ellipta41%Breo Ellipta20%Symbicort14%Budesonide-Formoterol Fumarate11%Fluticasone Propionate10%Breztri Aerosphere3%Mometasone Furoate3%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    6.6%
    Corticosteroid5.5%
    Prednisone100%
    Part D22 patients
    Proton pump inhibitor1%
    Pantoprazole Sodium100%
    Part D<11 patients
  • Cardiovascular

    4.9%
    Endothelin Receptor Antagonist3.3%
    Ambrisentan50%Opsumit50%
    Part D<11 patients
    Soluble Guanylate Cyclase Stimulator1.5%
    Adempas100%
    Part D<11 patients
Where care is delivered (Part B)85.8% facility · 14.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”